The Competition and Markets Authority has announced it is minded to accept a package of remedies to resolve antitrust issues arising from a massive healthcare property transaction. The regulatory watchdog’s initial investigation into the US-based real estate investment trust Welltower’s acquisition of more than 600 care homes across the United Kingdom had raised serious concerns about reduced choice and potential price hikes for elderly residents in dozens of communities.
The sweeping transaction, which was finalized in October 2025, saw Welltower take ownership of four extensive care home portfolios previously held and run by prominent providers, including Barchester Healthcare, HC-One, Aria Care, and Danforth Care. Following the purchase, the day-to-day management of these facilities was transferred to new operating firms, including Care UK and Apex Healthcare Properties. However, the antitrust authority’s phase one inquiry revealed that the consolidation could severely distort competition for residential and nursing care services across 30 localized markets spanning England and Scotland. In these specific areas, either Welltower or one of its chosen operators would control a dominant share of the available care facilities, leading to fears that the lack of local competition could drive up costs or diminish the quality of care provided to vulnerable residents.
To prevent the merger from being blocked or referred to an in-depth phase two investigation, Welltower has proactively put forward a series of binding commitments to restore local market balance. Under the proposed antitrust fix, the real estate investment trust will entirely divest its ownership of a number of the care home properties in the problematic regions. For other affected facilities, the company has pledged to strip management responsibilities from the current firms and reallocate the day-to-day operations to entirely independent, new operators.
The regulatory body has indicated that these structural and behavioral remedies have the potential to fully address its competition concerns. Officials emphasized that maintaining robust competition among local providers is absolutely vital to ensuring that older people and their families retain access to high-quality care options at reasonable prices. The competition watchdog plans to launch a formal public consultation on the details of the remedies package and the suitability of the potential buyers before granting final clearance to the multi-portfolio deal.
